Refine your search

Content type
Tags
Firm name
Author
Territory
Jurisdiction
Language

143,880 results found

Event

Nagashima Ohno & Tsunematsu | Asia-Pacific, Thailand | 31 Oct 2022

Business Laws Hot Topics of 2021 - Quarter 3

Article
Ask Lexy

Pallett Valo LLP | Canada | 19 May 2022

Medicine professional corporations

If you are a physician practicing in Ontario, you may be familiar with medicine professional corporations. Here are answers to the most common…
Article
Ask Lexy

CMS Cameron McKenna Nabarro Olswang LLP | China | 19 May 2022

Top developments and predictions in the Life Sciences & Healthcare sector in China

We look back to the top ten developments over the last 12 months in the life sciences and healthcare sector, and towards the future with our top ten…
Article
Ask Lexy

Taylor Wessing | European Union | 18 May 2022

Electronic instructions for use of medical devices - Requirements under new Implementing Regulation (EU) 2021/2226

As of January 2022, the provision of instructions for use for medical devices in electronic form instead of in paper form is governed by the new…
Article
Ask Lexy

LawPlus Ltd | Thailand | 18 May 2022

国政府采取进一步放宽大麻和火麻的使用措施

泰国社会长期以来一直认为大麻和火麻是具有医疗和其他健康益处的药用植物,但 1979 年《麻醉品法》B.E. (2522)("麻醉品法") 规定大麻和火麻为第 5类麻醉品。在泰国,与大麻和火有关的活动一直受到高度管制, 直到最近几年适用的法律逐渐放宽为止。…
Commentary
Ask Lexy

Smart & Biggar | Canada | 18 May 2022

CADTH proposals to enhance drug review processes

The Canadian Agency for Drugs and Technologies in Health recently held consultations on two new proposals: a proposed process for non-sponsored reimbursement reviews and a streamlined process for drug class reviews. The former is intended to apply to scenarios where a sponsor is unwilling or unable to file an application, while the latter would provide a new streamlined drug class review......
Article
Ask Lexy

Lakshmikumaran & Sridharan | India | 18 May 2022

Apex Laboratories: A bitter pill to swallow for the healthcare sector?

A contentious issue that has seen much litigation in the recent past is regarding the claim of expenditure under Section 37 of the Income-tax Act…
Commentary
Ask Lexy

Baker McKenzie | USA | 18 May 2022

Biden administration encouraging "allyshoring" of pharma and medical supply chains – survey reveals key trends among US life sciences companies

In the United States, the Biden administration has been focusing on policies to encourage onshoring, nearshoring, and even "allyshoring" of pharma and medical supply chains. The United States was chosen as the leading destination for manufacturing and supply chain operations by life sciences respondents of a recent survey globally, with over 52% of Americas respondents and 38% of North......
Article
Ask Lexy

Bristows | United Kingdom, USA | 18 May 2022

UK Biotech a mirror of the US market

That the UK biotech market is undergoing something of an investment boom is by now clear (and the subject of a separate article). But what this trend…
Commentary
Ask Lexy

K&S Partners | India | 18 May 2022

Indian patent law on pharmaceuticals: challenges and opportunities

Indian patent law on pharmaceuticals differs from other countries in several ways, some of which are among the most debated IP topics domestically. While some of these differences apply to non-pharmaceutical patents as well, the combination of these issues along with stricter patentability requirements poses significantly greater challenges to pharmaceutical patents. Despite such issues,......
Previous page 1 2 3 ...